Check out our most popular compounded medications! Get Started
Selegiline HCl 2.50 mg Oral Capsules are a solid dosage form consisting of two halves of either gelatin or vegetarian-based shells that encapsulate the medication. This design ensures the capsules are easy to swallow and provide a precise dose of Selegiline Hydrochloride, the active ingredient. Selegiline HCl is primarily used in the treatment of Parkinson's disease as it aids in the management of symptoms related to this condition. Additionally, it may be prescribed for patients with major depressive disorder as an adjunct treatment. The capsules are intended for oral administration.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Selegiline HCl 2.50 mg Oral Capsules are a solid dosage form consisting of two halves of either gelatin or vegetarian-based shells that encapsulate the medication. This form of medication is designed to be swallowed easily and to ensure that patients receive an exact dose of the active ingredient, Selegiline Hydrochloride, which is crucial for its effectiveness and safety. Each capsule contains 2.50 mg of Selegiline HCl, which is carefully measured to provide a consistent and precise dosage.
Selegiline HCl is primarily used in the treatment of Parkinson's disease, a neurodegenerative disorder characterized by the loss of dopamine-producing neurons in the brain. Selegiline acts as a selective monoamine oxidase inhibitor, specifically targeting the MAO-B enzyme. By inhibiting this enzyme, Selegiline helps to increase and prolong the activity of dopamine in the brain, thereby alleviating symptoms of Parkinson's disease such as tremors, stiffness, and slowness of movement. This medication may be used alone in the early stages of Parkinson's disease or in conjunction with other therapies such as levodopa/carbidopa as the disease progresses.
Additionally, Selegiline HCl has been investigated for its potential benefits in treating major depressive disorder, as it can enhance the effects of neurotransmitters in the brain. However, its use in depression is off-label and should be considered with caution, as it may interact with other medications and dietary components. Patients and prescribers should be aware of the potential for drug interactions and side effects, which can include, but are not limited to, dizziness, nausea, and insomnia. It is also important to avoid tyramine-rich foods while on this medication to prevent hypertensive crises.
For optimal therapeutic outcomes, it is essential that Selegiline HCl capsules are taken as prescribed and that patients adhere to their medication regimen. Regular monitoring by healthcare professionals is recommended to assess the effectiveness of the treatment and to make any necessary adjustments. If you have any questions or require further information about Selegiline HCl 2.50 mg Oral Capsules, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is committed to providing comprehensive support to both patients and prescribers to ensure the safe and appropriate use of this medication.
Selegiline HCl (hydrochloride) is a monoamine oxidase inhibitor (MAOI) that is primarily used to treat Parkinson's disease and, in some cases, major depressive disorder. It works by inhibiting the enzyme monoamine oxidase type B (MAO-B), which breaks down dopamine in the brain, thereby increasing the levels of dopamine and helping to improve motor symptoms in Parkinson's disease. When used for depression, it can enhance the effects of neurotransmitters in the brain.
When considering the use of Selegiline HCl 2.50 mg oral capsules, it is crucial to be aware of potential drug interactions that can lead to serious adverse effects or reduce the effectiveness of the treatment. Selegiline should not be used in combination with other MAOIs, as this can lead to a hypertensive crisis, a potentially life-threatening condition. Additionally, the use of Selegiline with serotonergic drugs, such as SSRIs, SNRIs, or tricyclic antidepressants, can increase the risk of serotonin syndrome, a serious condition characterized by symptoms such as confusion, hallucination, seizure, extreme changes in blood pressure, increased heart rate, fever, excessive sweating, shivering or shaking, blurred vision, muscle spasm or stiffness, tremor, incoordination, stomach cramp, nausea, vomiting, and diarrhea.
Patients should also avoid consuming foods high in tyramine, such as aged cheeses, cured meats, and fermented products, while taking Selegiline, as this can lead to a dangerous increase in blood pressure. Sympathomimetic medications, including decongestants and cold medications containing ephedrine or pseudoephedrine, should be used with caution due to the risk of hypertensive reactions. Additionally, Selegiline can interact with opioids, leading to increased risk of opioid toxicity.
It is important to inform healthcare providers of all medications being taken, including prescription drugs, over-the-counter medications, and herbal supplements, as Selegiline can interact with a wide range of substances. For example, anesthetics used during surgery can interact with Selegiline, so patients should inform their surgeon or dentist that they are taking this medication well in advance of any procedures.
Patients with a history of peptic ulcer disease or those taking anticoagulants should use Selegiline with caution, as there is a potential for gastrointestinal bleeding. Selegiline may also enhance the effects of antihypertensive medications, which could lead to hypotension. Adjustments in dosage or close monitoring may be necessary when Selegiline is used in conjunction with these medications.
Lastly, it is important to note that Selegiline has the potential to cause or exacerbate psychiatric symptoms, and its use should be carefully monitored in patients with a history of psychiatric disorders. If you have any questions or concerns regarding the use of Selegiline HCl 2.50 mg oral capsules or potential drug interactions, please reach out to us at Bayview Pharmacy for further assistance and professional advice.
Selegiline HCl 2.50 mg oral capsules are a solid dosage form that consists of two halves of either gelatin or vegetarian-based shells. These shells are designed to encapsulate the precise amount of Selegiline Hydrochloride, which is the active ingredient. The capsules are intended for oral administration, and their design facilitates easy swallowing, which can be particularly beneficial for patients who have difficulty taking tablets or other solid forms of medication. The encapsulation of the medication also helps to protect the active ingredient from degradation due to environmental factors such as light and moisture, ensuring the stability and efficacy of the medication until it is consumed.
Selegiline Hydrochloride, the active component in these capsules, is a selective monoamine oxidase inhibitor (MAOI) that is primarily used to treat Parkinson's disease and major depressive disorder. In the context of Parkinson's disease, Selegiline works by inhibiting the enzyme monoamine oxidase B (MAO-B) in the brain. MAO-B is responsible for breaking down dopamine, a neurotransmitter that is crucial for coordinating movement. By inhibiting this enzyme, Selegiline increases the levels of dopamine available in the brain, which helps to alleviate some of the symptoms of Parkinson's disease such as tremors, stiffness, and slowness of movement.
For the treatment of major depressive disorder, Selegiline's mechanism of action is slightly different. At higher doses, Selegiline inhibits both MAO-A and MAO-B, which leads to an increase in several neurotransmitters, including dopamine, norepinephrine, and serotonin. These neurotransmitters are known to play a role in mood regulation, and their increased availability in the brain can help to alleviate the symptoms of depression. However, it is important to note that the 2.50 mg dosage is typically used for Parkinson's disease, and higher doses would be required for the treatment of depression.
It is essential for patients and prescribers to understand that while Selegiline can help manage symptoms, it is not a cure for Parkinson's disease or depression. Additionally, patients should be aware of potential interactions with other medications and substances, as MAOIs can have serious interactions with certain drugs and tyramine-rich foods. Close monitoring by a healthcare provider is necessary when initiating or adjusting the dosage of Selegiline.
For any questions or concerns regarding Selegiline HCl 2.50 mg oral capsules, or to discuss the suitability of this medication for a particular patient, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide the necessary support and guidance to ensure appropriate treatment.
Selegiline HCl 2.50 mg Oral Capsule is used to treat symptoms associated with Parkinson's disease, often as an adjunct to levodopa/carbidopa therapy. It works by increasing and extending the effects of levodopa, and may help to slow the progression of disease symptoms.
Selegiline HCl capsules should be taken orally, usually twice daily as instructed by your healthcare provider. It's important to swallow the capsules whole, without crushing or chewing them, to ensure the medication is released properly in your body.
The capsule form of Selegiline HCl ensures a precise dose of medication is delivered, and the capsule's gelatin or vegetarian shell makes it easy to swallow. This dosage form can be particularly beneficial for those who have difficulty swallowing tablets.
Generally, the capsules should not be opened as they are designed to release the medication over a specific period. If you have difficulty swallowing capsules, consult your healthcare provider for advice on how to take this medication.
If you miss a dose, take it as soon as you remember. However, if it is near the time for your next dose, skip the missed dose and resume your regular dosing schedule. Do not double the dose to catch up.
There may be dietary restrictions while on Selegiline HCl, including avoiding foods that are high in tyramine to prevent hypertensive reactions. Alcohol can also cause interactions and should generally be avoided. Consult your healthcare provider for specific dietary recommendations and restrictions.
As with all medications, Selegiline HCl can cause side effects. Common side effects may include dizziness, nausea, dry mouth, abdominal pain, or insomnia. If you experience any severe side effects or symptoms of a hypertensive crisis, contact your healthcare professional immediately.
Selegiline can interact with certain medications, including antidepressants, opioids, and other medications used to treat Parkinson's disease. Always inform your healthcare provider of all the medications you are taking to avoid potential drug interactions.
Store Selegiline HCl capsules at room temperature away from light and moisture. Keep them out of reach of children and pets, and do not store them in the bathroom or near a sink.
Selegiline HCl can cause dizziness or drowsiness in some individuals. It is advisable not to drive or operate heavy machinery until you are sure you can perform such activities safely.
Inform your healthcare provider if you have any allergies, medical history of psychiatric disorders, ulcers, cardiovascular disease, or if you are using any other medication including prescription, over-the-counter, or herbal products. Also, discuss if you are pregnant or breastfeeding to ensure safe usage of Selegiline HCl capsules.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
